Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously ...

Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...